Searched for
DIABETES REVERSAL DRUG
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- India push into global natural healthcare market, government research institutions develop new drugsIndia's herbal healthcare sector is preparing for a new growth phase, as traditional medicine blends with modern science to produce validat...
- A number of healthtech startups claim they can reverse Type 2 diabetes. But caveats apply, caution doctorsLike LiveAltlife, which had a soft-launch in 2022 and will officially launch next month, a clutch of healthtech startups have launched prog...
- Being overweight ups risk of diabetes. New study explains why and tips to delay the onsetThe findings have been published in the journal Cell Metabolism.
- Fitterfly raises $12 million from Amazon Smbhav Venture Fund, othersFitterfly has managed over 20,000 patients till date through a 360-degree care approach and clinically prescribed therapy by more than 200 ...
- How much weight you should lose to keep your diabetes under control? Here is the answer"Treatment of obesity to achieve a sustained loss of 15 per cent body weight has been shown to have a major impact on type 2 diabetes progr...
- Sun Pharma recalls 50,868 bottles of diabetes drug in USDrug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to th...
- Indian drug firms recall various products in US marketWhile Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.
- Sun Pharma recalls 747 bottles of generic diabetes drug from the American marketAs per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Sun Pharmaceutical Industries is recalling the bottles...
- Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US marketAs per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydro...
- Indian drug firms recall products in US marketWhile Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US market.
- Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in USMacleods Pharma USA Inc has declared Pioglitazone Hydrochloride tablets used for treatment of diabetes in America to be superpotent which w...
- Type 2 diabetes can now be reversed, thanks to the less invasive 'surgery in a pill'Scientists have developed an effective treatment for reversing diabetes that can offer the same benefits as surgery.
- Adding broccoli to your diet will help keep diabetes under controlType 2 diabetes affects more than 300 mn people globally, and as many as 15% of those patients cannot take the first-line therapy .
- SC backs govt on fixing drug prices outside of essential listThe Bombay High Court had backed the government categorizing the drugs as essential and the need to make them affordable to a growing swath...
- Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US marketThe company is also recalling 7,694 bottles of anti- inflammatory drug indomethacin 25 mg, produced by Emcure Pharma, for non-adherence to ...
- FDA rejects Schering drug to reverse anesthesiaGovernment regulators dealt a major setback to Schering-Plough Corp, rejecting a highly anticipated drug designed to help patients recover ...
- DRL’s anti-diabetes drug to hit market by ’11Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...
- Novartis may route new drugs through subsidiaryContrary to investor expectations, Novartis may launch some of its new-patented drugs in India through its wholly-owned subsidiary.
Load More
